Although exogenous insulin and other drugs such as peroxisomeproliferator-activated receptor gamma (PPARγ) agonists may help control diabetes(1), long-term patients developprogressive complications including retinopathy, nephropathy, neuropathy, andcardiovascular disease (2). This evidence concerns the gene INS and diabetes mellitus.